Biogen applies for approval of Alzheimer’s drug, aducanumab in Japan Reuters Dec 10, 2020 Biogen and Eisai have jointly developed three experimental drugs for Alzheimer’s
Biogen moves forward with potential Alzheimer’s drug, seeks US FDA’s approval Reuters Jul 9, 2020 The drug, aducanumab, has had a tumultuous journey, with promising early data raising hopes and Biogen’s share price, only to be…
Biogen and Eisai revive plans for Alzheimer’s drug, surprising market Reuters Oct 23, 2019 The field of experimental Alzheimer’s treatments is littered with high-profile failures, with many major drugmakers abandoning the…
